217 related articles for article (PubMed ID: 26186960)
1. Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
Haimerl M; Schlabeck M; Verloh N; Zeman F; Fellner C; Nickel D; Barreiros AP; Loss M; Stroszczynski C; Wiggermann P
Eur Radiol; 2016 Apr; 26(4):1125-33. PubMed ID: 26186960
[TBL] [Abstract][Full Text] [Related]
2. Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry.
Haimerl M; Verloh N; Zeman F; Fellner C; Nickel D; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
Sci Rep; 2017 Mar; 7():43347. PubMed ID: 28266528
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.
Yoneyama T; Fukukura Y; Kamimura K; Takumi K; Umanodan A; Ueno S; Nakajo M
Eur Radiol; 2014 Apr; 24(4):857-65. PubMed ID: 24356768
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
Yamada A; Hara T; Li F; Fujinaga Y; Ueda K; Kadoya M; Doi K
Radiology; 2011 Sep; 260(3):727-33. PubMed ID: 21712472
[TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
9. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
10. Liver function test by gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging with consideration of intrahepatic regional differences.
Okubo H; Mogami M; Ozaki Y; Igusa Y; Aoyama T; Amano M; Kokubu S; Miyazaki A; Watanabe S
Hepatogastroenterology; 2013 Oct; 60(127):1547-51. PubMed ID: 23933786
[TBL] [Abstract][Full Text] [Related]
11. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.
Kanki A; Tamada T; Higaki A; Noda Y; Tanimoto D; Sato T; Higashi H; Ito K
Magn Reson Imaging; 2012 Apr; 30(3):356-60. PubMed ID: 22227353
[TBL] [Abstract][Full Text] [Related]
12. Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.
Dahlqvist Leinhard O; Dahlström N; Kihlberg J; Sandström P; Brismar TB; Smedby O; Lundberg P
Eur Radiol; 2012 Mar; 22(3):642-53. PubMed ID: 21984449
[TBL] [Abstract][Full Text] [Related]
13. Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention.
Saito K; Ledsam J; Sourbron S; Hashimoto T; Araki Y; Akata S; Tokuuye K
Eur Radiol; 2014 Jan; 24(1):112-9. PubMed ID: 23949726
[TBL] [Abstract][Full Text] [Related]
14. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
16. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
[TBL] [Abstract][Full Text] [Related]
18. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
[TBL] [Abstract][Full Text] [Related]
19. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.
Kim HY; Choi JY; Park CH; Song MJ; Song DS; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE
J Gastroenterol; 2013 Oct; 48(10):1180-7. PubMed ID: 23354621
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
